Detalhe da pesquisa
1.
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
Biol Blood Marrow Transplant
; 21(12): 2091-2099, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26253007
2.
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.
Biol Blood Marrow Transplant
; 20(1): 89-97, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24161923
3.
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.
Biol Blood Marrow Transplant
; 20(2): 202-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24184335
4.
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.
Biol Blood Marrow Transplant
; 20(7): 960-8, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24641829
5.
Providing personalized prognostic information for adult leukemia survivors.
Biol Blood Marrow Transplant
; 19(11): 1600-7, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24018394
6.
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.
Commun Med (Lond)
; 3(1): 14, 2023 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750617
7.
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
Cancer Res Commun
; 3(7): 1335-1349, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497337
8.
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.
Biol Blood Marrow Transplant
; 18(8): 1255-64, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22198543
9.
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.
Biol Blood Marrow Transplant
; 18(2): 280-8, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21810400
10.
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).
Biol Blood Marrow Transplant
; 14(12): 1323-33, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19041053
11.
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.
Transplantation
; 86(2): 215-22, 2008 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-18645482
12.
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.
J Clin Oncol
; 34(16): 1864-71, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27044940
13.
Acute myelogenous leukemia at Baylor Charles A. Sammons Cancer Center, 2010 to 2012: retrospective analysis of molecular genetic evaluation.
Proc (Bayl Univ Med Cent)
; 27(4): 299-304, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25484493
14.
Model for the cost-efficient delivery of continuous quality cancer care: a hospital and private-practice collaboration.
Proc (Bayl Univ Med Cent)
; 26(2): 95-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23543960
15.
Advance care planning knowledge and documentation in a hospitalized cancer population.
Proc (Bayl Univ Med Cent)
; 26(4): 368-72, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24082411
16.
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.
Blood
; 101(7): 2476-82, 2003 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12456505